Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

121 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Antiplatelet and antithrombotic treatment after transcatheter aortic valve implantation - comparison of regimes.
Poliacikova P, Cockburn J, de Belder A, Trivedi U, Hildick-Smith D. Poliacikova P, et al. Among authors: de belder a. J Invasive Cardiol. 2013 Oct;25(10):544-8. J Invasive Cardiol. 2013. PMID: 24088430
METHODS: We analyzed a cohort of 171 patients with symptomatic severe aortic stenosis who underwent TAVI using the CoreValve (Medtronic, Inc) in our center between December 2007 and June 2012. ...This difference was driven mainly by bleeding complications, with a tr …
METHODS: We analyzed a cohort of 171 patients with symptomatic severe aortic stenosis who underwent TAVI using the CoreValve (Medtron …
Development and validation of a Bayesian index for predicting major adverse cardiac events with percutaneous transluminal coronary angioplasty.
de Belder AJ, Jewitt DE, Wainwright RJ, Thomas MR. de Belder AJ, et al. Heart. 2001 Jan;85(1):69-72. doi: 10.1136/heart.85.1.69. Heart. 2001. PMID: 11119467 Free PMC article.
OBJECTIVE: To create a risk model for predicting major adverse complicating events of percutaneous transluminal coronary angioplasty (PTCA), and to test the accuracy of the model on a prospective cohort of patients SETTING: Tertiary cardiac centre METHODS: Available …
OBJECTIVE: To create a risk model for predicting major adverse complicating events of percutaneous transluminal coronary angioplasty …
Transcatheter aortic valve implantation for stenosed and regurgitant aortic valve bioprostheses CoreValve for failed bioprosthetic aortic valve replacements.
Khawaja MZ, Haworth P, Ghuran A, Lee L, de Belder A, Hutchinson N, Trivedi U, Laborde JC, Hildick-Smith D. Khawaja MZ, et al. Among authors: de belder a. J Am Coll Cardiol. 2010 Jan 12;55(2):97-101. doi: 10.1016/j.jacc.2009.06.060. J Am Coll Cardiol. 2010. PMID: 20117377
Therefore, there is a corresponding increase in prosthetic degeneration. This presents cardiologists with a cohort of patients for whom the risk of re-do aortic valve surgery is prohibitive. ...
Therefore, there is a corresponding increase in prosthetic degeneration. This presents cardiologists with a cohort of patients …
Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.
Kapur A, Hall RJ, Malik IS, Qureshi AC, Butts J, de Belder M, Baumbach A, Angelini G, de Belder A, Oldroyd KG, Flather M, Roughton M, Nihoyannopoulos P, Bagger JP, Morgan K, Beatt KJ. Kapur A, et al. Among authors: de belder m, de belder a. J Am Coll Cardiol. 2010 Feb 2;55(5):432-40. doi: 10.1016/j.jacc.2009.10.014. J Am Coll Cardiol. 2010. PMID: 20117456 Clinical Trial.
A total of 510 diabetic patients with multivessel or complex single-vessel coronary disease from 24 centers were randomized to PCI plus stenting (and routine abciximab) or CABG. The primary comparison used a noninferiority method with the upper boundary of the 95% c
A total of 510 diabetic patients with multivessel or complex single-vessel coronary disease from 24 centers were randomized to PCI pl
Prognostic benefit of transcatheter aortic valve implantation compared with medical therapy in patients with inoperable aortic stenosis.
Rajani R, Buxton W, Haworth P, Khawaja MZ, Sohal M, Brum RL, Hutchinson N, de Belder A, Trivedi U, Hildick-Smith D. Rajani R, et al. Among authors: de belder a. Catheter Cardiovasc Interv. 2010 Jun 1;75(7):1121-6. doi: 10.1002/ccd.22418. Catheter Cardiovasc Interv. 2010. PMID: 20146205
Among the medically-treated patients, 14 (30%) underwent palliative balloon aortic valvuloplasty, with a trend toward improved survival (P = 0.06). During overall follow-up of 215 +/- 115 days there were a total of 18 deaths; TAVI N = 5 (13%); Medical N = 13 (28%) ( …
Among the medically-treated patients, 14 (30%) underwent palliative balloon aortic valvuloplasty, with a trend toward improved surviv …
Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategies.
Hildick-Smith D, de Belder AJ, Cooter N, Curzen NP, Clayton TC, Oldroyd KG, Bennett L, Holmberg S, Cotton JM, Glennon PE, Thomas MR, Maccarthy PA, Baumbach A, Mulvihill NT, Henderson RA, Redwood SR, Starkey IR, Stables RH. Hildick-Smith D, et al. Among authors: de belder aj. Circulation. 2010 Mar 16;121(10):1235-43. doi: 10.1161/CIRCULATIONAHA.109.888297. Epub 2010 Mar 1. Circulation. 2010. PMID: 20194880 Clinical Trial.
METHODS AND RESULTS: Patients with significant coronary bifurcation lesions were randomized to either a simple or complex stenting strategy with drug-eluting stents. ...CONCLUSIONS: When coronary bifurcation lesions are treated, a systematic 2-stent technique result …
METHODS AND RESULTS: Patients with significant coronary bifurcation lesions were randomized to either a simple or complex stenting st …
Rescue angioplasty for failed fibrinolysis--long-term follow-up of a large cohort.
Sohal M, Foo F, Sirker A, Rajani R, Khawaja MZ, Pegge N, Hatrick R, Kneale B, Signy M, Holmberg S, de Belder A, Hildick-Smith D. Sohal M, et al. Among authors: de belder a. Catheter Cardiovasc Interv. 2011 Apr 1;77(5):599-604. doi: 10.1002/ccd.22771. Epub 2010 Oct 6. Catheter Cardiovasc Interv. 2011. PMID: 20824771
BACKGROUND: Fibrinolysis remains an important treatment for ST-elevation myocardial infarction, but fails to achieve adequate reperfusion in a significant proportion of cases. ...Periprocedural data was taken from a dedicated procedural database and mortality data o …
BACKGROUND: Fibrinolysis remains an important treatment for ST-elevation myocardial infarction, but fails to achieve adequate reperfusion in …
Predictors for permanent pacing after transcatheter aortic valve implantation.
Haworth P, Behan M, Khawaja M, Hutchinson N, de Belder A, Trivedi U, Laborde JC, Hildick-Smith D. Haworth P, et al. Among authors: de belder a. Catheter Cardiovasc Interv. 2010 Nov 1;76(5):751-6. doi: 10.1002/ccd.22457. Catheter Cardiovasc Interv. 2010. PMID: 20927783
PR interval increased after the procedure by 23.5 ± 23.9 ms and peaked at day 4 with a mean increase of 66.1 ± 72.7 ms. QRS duration increased by a mean of 30.6 ± 26.1 ms postprocedure and remained stable thereafter during the remaining hospital stay. The need for P …
PR interval increased after the procedure by 23.5 ± 23.9 ms and peaked at day 4 with a mean increase of 66.1 ± 72.7 ms. QRS duration …
Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative).
Khawaja MZ, Rajani R, Cook A, Khavandi A, Moynagh A, Chowdhary S, Spence MS, Brown S, Khan SQ, Walker N, Trivedi U, Hutchinson N, De Belder AJ, Moat N, Blackman DJ, Levy RD, Manoharan G, Roberts D, Khogali SS, Crean P, Brecker SJ, Baumbach A, Mullen M, Laborde JC, Hildick-Smith D. Khawaja MZ, et al. Among authors: de belder aj. Circulation. 2011 Mar 8;123(9):951-60. doi: 10.1161/CIRCULATIONAHA.109.927152. Epub 2011 Feb 21. Circulation. 2011. PMID: 21339482
Eighty-one patients (33.3%) required a PPM within 30 days. Rates of pacing according to preexisting ECG abnormalities were as follows: right bundle-branch block, 65.2%; left bundle-branch block, 43.75%; normal QRS, 27.6%. ...CONCLUSION: One third of patients undergoing …
Eighty-one patients (33.3%) required a PPM within 30 days. Rates of pacing according to preexisting ECG abnormalities were as follows …
Large calibre arterial access device closure for percutaneous aortic valve interventions: use of the Prostar system in 118 cases.
Cockburn J, de Belder A, Brooks M, Hutchinson N, Hill A, Trivedi U, Hildick-Smith D. Cockburn J, et al. Among authors: de belder a. Catheter Cardiovasc Interv. 2012 Jan 1;79(1):143-9. doi: 10.1002/ccd.23105. Epub 2011 Dec 8. Catheter Cardiovasc Interv. 2012. PMID: 21538787
Procedural data and outcomes were collected prospectively on a dedicated database. RESULTS: Patients were aged 80 ± 6.9 years (BAV) and 80.8 ± 6.1 years (TAVI) and 46.2% (BAV) and 46.8% (TAVI) were male, respectively. ...CONCLUSIONS: Use of the Prostar vascular closure sys …
Procedural data and outcomes were collected prospectively on a dedicated database. RESULTS: Patients were aged 80 ± 6.9 years (BAV) a …
121 results
Jump to page
Feedback